Contents

Current Medicinal Chemistry, Volume 20 - Number 34

Editorial:Metabolic, Pathological, and Therapeutic Perspectives Intracellular 5’-Nucleotidases.

, 20(34): 4203 - 4204

Piero Luigi Ipata and Maria Grazia Tozzi


DOI: 10.2174/0929867311320340001




The Functional Logic of Cytosolic 5’-Nucleotidases.

, 20(34): 4205 - 4216

P. L. Ipata and F. Balestri


DOI: 10.2174/0929867311320340002




5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications

, 20(34): 4217 - 4240

Zsolt Kovács, Árpád Dobolyi, Katalin A. Kékesi and Gábor Juhász


DOI: 10.2174/0929867311320340003




Is the Expression of Deoxynucleoside Kinases and 5'-nucleotidases in Animal Tissues Related to the Biological Effects of Nucleoside Analogs?

, 20(34): 4241 - 4248

Staffan Eriksson


DOI: 10.2174/0929867311320340004




The Role of Soluble 5' -Nucleotidases in the Conversion of Nucleotide Analogs: Metabolic and Therapeutic Aspects

, 20(34): 4249 - 4259

A. C. Sk ładanowski


DOI: 10.2174/0929867311320340005




Enzymatic Properties and Physiological Roles of Cytosolic 5’-Nucleotidase II.

, 20(34): 4260 - 4284

Roichi Itoh


DOI: 10.2174/0929867311320340006




On the Physiological Role of Cytosolic 5’-nucleotidase II (cN-II): Pathological and Therapeutical Implications.

, 20(34): 4285 - 4291

M. G. Tozzi, R. Pesi and S. Allegrini


DOI: 10.2174/0929867311320340007




Therapeutic Perspectives for cN-II in Cancer.

, 20(34): 4292 - 4303

Lars Petter Jordheim and Laurent Chaloin


DOI: 10.2174/0929867311320340008




The Enzymology of Cytosolic Pyrimidine 5’-Nucleotidases: Functional Analysis and Physiopathological Implications.

, 20(34): 4304 - 4316

Giulio Magni, Adolfo Amici and Giuseppe Orsomando


DOI: 10.2174/0929867311320340009




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science